Similar articles

• Extrapyramidal symptoms from intravenous haloperidol in the treatment of delirium.

  Blitzstein SM, Brandt GT. Blitzstein SM, et al. Am J Psychiatry. 1997 Oct;154(10):1474-5. doi: 10.1176/ajp.154.10.1474b. Am J Psychiatry. 1997. PMID: 9326840 No abstract available.
• Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care in hospitalized elderly adults.

  Cheung D, Wolfe B, Wald H, Cumbler E. Cheung D, et al. J Am Geriatr Soc. 2013 Jan;61(1):160-1. doi: 10.1111/jgs.12049. J Am Geriatr Soc. 2013. PMID: 23311558 No abstract available.
• Management of Multifactorial Infant Delirium with Intravenous Haloperidol in the Setting of Over Sedation and Poor Enteral Absorption.

  Carlton EF, Mahowald MK, Malas N. Carlton EF, et al. J Child Adolesc Psychopharmacol. 2017 Apr;27(3):289-290. doi: 10.1089/cap.2016.0103. Epub 2016 Nov 28. J Child Adolesc Psychopharmacol. 2017. PMID: 27893294 No abstract available.
• Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients.

  Schrader SL, Wellik KE, Demaerschalk BM, Caselli RJ, Woodruff BK, Wingerchuk DM. Schrader SL, et al. Neurologist. 2008 Mar;14(2):134-7. doi: 10.1097/NRL.0b013e318166b88c. Neurologist. 2008. PMID: 18332845 Review.
• Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.

  Rea RS, Battistone S, Fong JJ, Devlin JW. Rea RS, et al. Pharmacotherapy. 2007 Apr;27(4):588-94. doi: 10.1592/phco.27.4.588. Pharmacotherapy. 2007. PMID: 17381385 Review.